DK51590A - System til topisk afgivelse - Google Patents

System til topisk afgivelse Download PDF

Info

Publication number
DK51590A
DK51590A DK051590A DK51590A DK51590A DK 51590 A DK51590 A DK 51590A DK 051590 A DK051590 A DK 051590A DK 51590 A DK51590 A DK 51590A DK 51590 A DK51590 A DK 51590A
Authority
DK
Denmark
Prior art keywords
delivery system
topical delivery
topical
delivery
Prior art date
Application number
DK051590A
Other languages
English (en)
Other versions
DK51590D0 (da
Inventor
Tully J Speaker
Frank N Chang
Stephen C Hsu
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Publication of DK51590A publication Critical patent/DK51590A/da
Publication of DK51590D0 publication Critical patent/DK51590D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK051590A 1988-06-28 1990-02-27 System til topisk afgivelse DK51590D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/212,492 US4917892A (en) 1988-06-28 1988-06-28 Encapsulated topical delivery system
PCT/US1989/002643 WO1990000048A1 (en) 1988-06-28 1989-06-16 Topical delivery system

Publications (2)

Publication Number Publication Date
DK51590A true DK51590A (da) 1990-02-27
DK51590D0 DK51590D0 (da) 1990-02-27

Family

ID=22791250

Family Applications (1)

Application Number Title Priority Date Filing Date
DK051590A DK51590D0 (da) 1988-06-28 1990-02-27 System til topisk afgivelse

Country Status (9)

Country Link
US (1) US4917892A (da)
EP (1) EP0393164A4 (da)
JP (1) JPH03501485A (da)
AU (1) AU613298B2 (da)
DK (1) DK51590D0 (da)
NZ (1) NZ229356A (da)
PT (1) PT90994A (da)
WO (1) WO1990000048A1 (da)
ZA (1) ZA894308B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2659554B1 (fr) 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
AU629316B2 (en) * 1990-04-11 1992-10-01 Flora Inc. Periodontal disease treatment system
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5284663A (en) * 1991-07-23 1994-02-08 Temple University Salt film encapsulated perfluorocarbons
AU675206B2 (en) * 1991-09-13 1997-01-30 Gillette Canada Inc. Polymeric particles for dental applications
WO1993011754A1 (en) * 1991-12-11 1993-06-24 The Procter & Gamble Company Cetylpyridinium chloride and domiphen bromide in organic solvent
US5571525A (en) * 1992-03-30 1996-11-05 Alza Corporation Erosion rate modifier for use in bioerodible drug delivery devices and method of use
ZA932272B (en) * 1992-03-30 1993-10-19 Alza Corp Viscous suspensions of controlled-release drug particles
US5759566A (en) * 1992-07-28 1998-06-02 Poli Industria Chimica Spa Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents
IT1255460B (it) * 1992-07-28 1995-11-02 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive
US5654000A (en) * 1992-07-28 1997-08-05 Poli Industria Chimica S.P.A. Pharmaceutical compositions for transmucosal delivery of peptides
DE69530227T2 (de) * 1994-04-15 2004-04-01 Temple University Methode zum einkapseln mittels eines wässrigen lösungsmittels und mikrokapseln
US6531156B1 (en) 1994-04-15 2003-03-11 Temple University Aqueous solven encapsulation method, apparatus and microcapsules
US5616315A (en) * 1994-10-13 1997-04-01 Gillette Canada Inc. Particles including degradable material and anti-microbial agent
TW412425B (en) * 1994-10-18 2000-11-21 Kao Corp Dentifrice composition having capsule particles
US5660817A (en) * 1994-11-09 1997-08-26 Gillette Canada, Inc. Desensitizing teeth with degradable particles
US6193994B1 (en) * 1996-05-23 2001-02-27 Samyang Corporation Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
KR100232645B1 (ko) * 1997-05-22 1999-12-01 김윤 국소 투여형 생분해성 서방형 치주염 치료제 조성물 및 그 제조 방법
DE29908415U1 (de) * 1999-05-18 1999-07-22 Carl, Wolfgang, Dr.med.dent., 66386 St Ingbert Mittel zur Behandlung lokaler parodontaler Infektionen
WO2001043698A1 (en) * 1999-12-15 2001-06-21 Carter Donald R Topical ointment
CA2427543A1 (en) * 2000-03-15 2004-11-02 Yu-Ling Cheng Thermally reversible implant and filler
US6676958B2 (en) 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
US20030198682A1 (en) * 2002-02-12 2003-10-23 Gruber James V. Composition and method for protecting labile active components during high temperature drying
CN100346762C (zh) * 2002-11-04 2007-11-07 沛瑞丹泰斯实验公司 口腔卫生***及理疗方法
CA2523484A1 (en) * 2003-05-02 2004-11-11 Rimon Therapeutics Ltd. Thermally reversible implant
WO2006063030A1 (en) 2004-12-08 2006-06-15 Speaker Tycho J Microencapsulation product and process
GB0427520D0 (en) * 2004-12-16 2005-01-19 Univ Hull Magnetic resonance contrast media
WO2007012856A1 (en) * 2005-07-28 2007-02-01 University Of Hull Uses of sporopollenin
WO2008011556A2 (en) * 2006-07-20 2008-01-24 Izun Pharmaceuticals Corporation Film-delivering rinse
US20080292663A1 (en) * 2007-05-22 2008-11-27 Gerber Jay D Adjuvant compositions and methods for delivering vaccines
GB0812513D0 (en) * 2008-07-09 2008-08-13 Univ Hull Delivery vehicle
US20100129448A1 (en) * 2008-08-18 2010-05-27 Nanotherapeutics, Inc. Topical hydrogel composition
CA3081072A1 (en) 2012-03-12 2013-09-19 Advanced Bioadjuvants, Llc Adjuvant and vaccine compositions
US9744106B2 (en) 2013-05-28 2017-08-29 Capsulent Products containing charged polymer complex microcapsules and method of use
CA2951513A1 (en) * 2014-06-09 2015-12-17 Klox Technologies Inc. Silicone-based biophotonic compositions and uses thereof
DE102016101280A1 (de) 2016-01-26 2017-07-27 Frank Bröseler Pharmazeutische Zusammensetzung
KR20200083540A (ko) * 2017-11-01 2020-07-08 머크 샤프 앤드 돔 코포레이션 시토메갈로바이러스의 안정한 제형

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959457A (en) * 1970-06-05 1976-05-25 Temple University Microparticulate material and method of making such material
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
US4145408A (en) * 1976-08-16 1979-03-20 The Procter & Gamble Company Controlled release article
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
GB8421706D0 (en) * 1984-08-28 1984-10-03 Pharmaceutical Holdings Ltd Pharmaceutical preparations
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
US4743583A (en) * 1987-07-20 1988-05-10 Temple University Sustained release protein compositions and method for making

Also Published As

Publication number Publication date
PT90994A (pt) 1989-12-29
EP0393164A4 (en) 1991-07-03
WO1990000048A1 (en) 1990-01-11
DK51590D0 (da) 1990-02-27
US4917892A (en) 1990-04-17
ZA894308B (en) 1990-02-28
NZ229356A (en) 1991-02-26
AU3851889A (en) 1990-01-23
EP0393164A1 (en) 1990-10-24
AU613298B2 (en) 1991-07-25
JPH03501485A (ja) 1991-04-04

Similar Documents

Publication Publication Date Title
DK51590D0 (da) System til topisk afgivelse
DK313589A (da) Formastersystem
DK453585D0 (da) Laegemiddel-indgivelsessystem
NO931499D0 (no) Konstruksjonselement-monteringssystem
DE68926340D1 (de) Frankiersystem
NO894666D0 (no) Elektroakustisk system.
DE68910979D1 (de) Verbindungssystem.
FI894688A0 (fi) Flytande oralt tagbart terapeutiskt system.
DE3650223D1 (de) Flockenbelieferungsanlage.
DE68928774D1 (de) Kamarasystem
FI901125A0 (fi) Smakgivande system foer fettfria livsmedel.
DE68924369D1 (de) Mikroprozessorsystem.
DE68919919D1 (de) Anzeigesystem.
DE68920870D1 (de) Tastaturbedientes system.
NO900927L (no) Topisk avleveringssystem.
NO901018L (no) Topisk hematopofyrin.
DK52590D0 (da) Afgivelseslukke
DE3676095D1 (de) Fadenliefersystem.
DK593889D0 (da) Elektroakustisk system
ATA91887A (de) Schankanlage
DK678488D0 (da) Byggesystem
IT8816905A0 (it) Totomatik system electronix
SE8903122D0 (sv) System
IT8818406V0 (it) Totomatik system electronix
NO885669D0 (no) Forskalingssystem.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment